(RTTNews) - Alcon, a division of Novartis, announced it has received approval from the US FDA for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens with ACTIVEFOCUS optical design for ...

Slit lamp photo of the ReStor IOL in the eye. (All images courtesy of Francesco Carones, MD.) BARCELONA – The apodized optic design of the pseudoaccomodative Alcon AcrySof ReStor IOL may overcome the ...

Patients were equally satisfied with two market-leading multifocal intraocular (IOL) lenses, the Carl Zeiss Meditec AT LISA 809M and the Alcon AcrySof ReSTOR SN6AD1 IOL, each of which allowed ...

FORT WORTH, Texas--(BUSINESS WIRE)--April 25, 2005--Alcon, Inc., (NYSE:ACL) announced the launch of the AcrySof(R) ReSTOR(R) Intraocular Lens (IOL) at a press conference during the American Society of ...

Novartis' ($NVS) Alcon received FDA approval for its implantable AcrySof IQ ReSTOR +2.5 Diopter intraocular lens (IOL), enabling vision correction at all distances in ...

Implantation of a multifocal IOL resulted in a greater incidence of posterior capsule opacification than a monofocal lens, a study showed. "Reasons for this may include increased visual demands of ...

The FDA's Ophthalmic Devices Advisory Committee panel overwhelmingly recommended PMA approval of Alcon's AcrySof IQ ReSTOR Multifocal Toric Intraocular Lens for patients undergoing cataract eye ...

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...